We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LSB market cap is 49.04M. The company's latest EPS is CNY -22.7174 and P/E is 0.00.
Quarter End | Jun 2023 | Sep 2023 | ||
---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Total Revenue | 176.27M | 96.82M | ||
Operating Income | -70.05M | -113.21M | ||
Net Income | -69.54M | -104.98M |
Year End March 30 2024 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Total Revenue | 257.02M | 502.95M | 687.2M | 573.42M |
Operating Income | -125.85M | -118.96M | -139.38M | -445.83M |
Net Income | -208.44M | -236.67M | -283.47M | -433.47M |
Quarter End | Jun 2023 | Sep 2023 | ||
---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Total Assets | 1.69B | 1.61B | ||
Total Liabilities | 1.03B | 1.05B | ||
Total Equity | 660.75M | 557.1M |
Year End March 30 2024 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Total Assets | 1.17B | 1.44B | 1.72B | 1.51B |
Total Liabilities | 390.58M | 770.5M | 991.3M | 927.82M |
Total Equity | -508.86M | -698.97M | 728.45M | 585.21M |
Quarter End | Jun 2023 | Sep 2023 | ||
---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Operating | N/A | -145.83M | ||
Investing | N/A | -23.42M | ||
Financing | N/A | 44.86M |
Year End March 30 2024 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
Operating | -246.61M | -173.55M | -182.47M | -295.23M |
Investing | -104.24M | -298.92M | -56.98M | -44.25M |
Financing | 739.26M | 364.56M | 317.45M | 205.26M |
Market Cap | 49.04M |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0.01 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 19.08M |
Average Volume (1 week) | 15.73k |
Average Volume (1 Month) | 73.07k |
52 Week Change | -76.42% |
52 Week High | 11.20 |
52 Week Low | 1.88 |
Spread (Intraday) | 0.55 (19.64%) |
Company Name | LakeShore Biopharma Company Ltd |
Address |
building no. 2 beijing |
Website | https://www.yishengbio.com. |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions